The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
MeiraGTx Holdings plc COM G59665102 134,175,107 12,197,737 SH SOLE 12,197,737 0 0
Inhibrx Biosciences, Inc. COM 45720N103 115,885,234 1,157,926 SH SOLE 1,157,926 0 0
Novavax COM NEW 670002401 74,378,000 6,880,481 SH SOLE 6,880,481 0 0
Korsana Biosciences COM 23255M303 63,808,352 1,994,011 SH SOLE 1,994,011 0 0
Odyssey Therapeutics Inc. COMMON STOCK 67613T104 44,222,244 1,990,200 SH SOLE 1,990,200 0 0
Electra Therapeutics Inc COM 284825106 27,696,915 2,461,948 SH SOLE 2,461,948 0 0
AnaptysBio COM 032724106 41,309,548 821,917 SH SOLE 821,917 0 0
Agomab Therapeutics NV SPONSORED ADS 00860C102 30,892,366 2,783,096 SH SOLE 2,783,096 0 0
First Tracks Biotherapeutics Inc. ORD SHS 337185102 29,128,738 821,917 SH SOLE 821,917 0 0
Attovia Therapeutics Inc COM 04987L102 18,560,135 1,082,855 SH SOLE 1,082,855 0 0
Latigo Biotherapeutics Inc COM 517954103 11,235,393 672,778 SH SOLE 672,778 0 0
Immuneering Corp CLASS A COM 45254E107 11,091,549 2,708,559 SH SOLE 2,708,559 0 0
MapLight Therapeutics Inc. COM 56565P103 9,293,698 912,041 SH SOLE 912,041 0 0
Scribe Therapeutics COM 811033109 9,202,500 500,000 SH SOLE 500,000 0 0
Q32 Bio Inc. COM 746964105 2,018,566 244,083 SH SOLE 244,083 0 0
SAB BIOTHERAPEUTICS INC COM NEW 78397T202 6,969,245 2,198,500 SH SOLE 2,198,500 0 0